Search Results
357 items found for "Interferon regulatory factor 1"
- Trevena Announce Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu ...
eligible to receive future success payments upon approval and commercialization milestones, as well as a 10%
- Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of ...
agonist-promoted degradation of wild type CXCR4 was effectively inhibited by the CXCR4 antagonist TE-14016
- Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes
Simulations were performed using 37 experimental structures of 11 Class A GPCR crystallized in multiple Median ligand RMSD values for top-scored poses were 1.2 Å and 2.0 Å for self-docking and StateMatch/FunctionMatch
- Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
Dimensionality reduction analysis shows that Nb80 stabilizes structural features of the β2AR with an ∼14
- Phospholipid Scrambling by G Protein-Coupled Receptors
In liposomes, opsin scrambles lipids at a unitary rate of >100,000 per second.
- A Model for the Signal Initiation Complex Between Arrestin-3 and the Src Family Kinase Fgr
provide a framework for this interaction, we determined the crystal structure of the Fgr SH3 domain at 1.9
- G protein-coupled receptor interactions and modification of signalling involving the ghrelin ...
modification of signalling involving the ghrelin receptor, GHSR1a The growth hormone secretagogue receptor 1a Typically, ghrelin-dependent and constitutive GHSR1a activation occurs via Gαq/11 pathways.
- The mouse cytomegalovirus G protein-coupled receptor homolog, M33, coordinates key features of ...
M33 engages Gq/11 to constitutively activate phospholipase C β (PLCβ) and downstream cyclic AMP response-element Following intranasal infection with MCMV M33ΔC38, the absence of M33 CREB Gq/11-dependent signalling
- Chemical signaling regulates axon regeneration via the GPCR-Gqα pathway in Caenorhabditis elegans
Caenorhabditis elegans We find that the enzymes involved in ascaroside pheromone biosynthesis, ACOX-1.1 , ACOX-1.2, and DAF-22, participate in axon regeneration by producing a dauer-inducing ascaroside, ascr activating mutation in egl-30 encoding Gqα suppresses axon regeneration defective phenotype in acox-1.1
- Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas ...
[BMB Reports 2021; 54(12): 601-607]. Read full article
- Chronic itch: emerging treatments following new research concepts
Currently, inhibitors of IL-31, IL-4/13, NK1 receptors, opioids and cannabinoids, JAK, PDE4 or TRP are
- Melatonin MT 2 receptor is expressed and potentiates contraction in human airway smooth muscle
Activation of melatonin MT2 receptors with either pharmacological concentrations of melatonin (10-100 µM) or the nonselective MT1/MT2 agonist ramelteon (10 µM) significantly inhibited forskolin-stimulated
- The development of modulators for lysophosphatidic acid receptors: A comprehensive review
pulmonary fibrosis (BMS-986020 and BMS-986278) and systemic sclerosis (SAR100842), and one radioligand (BMT-136088 /18F-BMS-986327) has entered phase Ⅰ clinical trials for positron emission tomography (PET) imaging of
- Coordinated transcriptomics and peptidomics of central nervous system identify neuropeptides and ...
Overall, 57 neuropeptide precursor genes were identified and 128 various mature peptides were predicted of CNS of G. molesta, we identified total of 28 mature peptides and precursor-related peptides from 16
- Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop ...
to generate novel antibody leads to disease-relevant GPCR targets Tokyo, Japan and Cambridge, UK, 16
- Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed...
Established in 1966, ASCEPT is affiliated with the International Union of Basic and Clinical Pharmacology
- VIB spin-off Confo Therapeutics Enters Collaborative Agreement with Regeneron
December 2021 "30/11/2021 Confo will work together with Regeneron to apply its GPCR drug discovery
- Crinetics Pharmaceuticals announced the formation of an independently operated new company...
Pipeline is Built from Crinetics’ Core Nonpeptide Platform and Includes Drug Candidates and Leads Against 10 Targets – Radionetics and Crinetics to Collaborate on Multiple Additional targets SAN DIEGO, October 18
- Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team
November 2021 "November 11, 2021 7:00am EST Patricia Drake appointed new Chief Commercial Officer CHESTERBROOK , Pa., Nov. 11, 2021 -- Trevena , Inc.
- Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European ...
. , Nov. 12, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx , Inc. , (Nasdaq: CCXI), today announced that the
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
November 2021 "Nov. 15, 2021 LONDON – There’s not yet proof of the pudding, but Omass Therapeutics Ltd